• OPEN AN ACCOUNT
Indian Indices
Sensex
71,841.28 -639.01
( -0.88%)
Global Indices
Nasdaq
50,945.10 -425.82
(-0.83%)
Dow Jones
7,674.56 -17.28
(-0.22%)
Hang Seng
68,949.71 2,195.99
(3.29%)
Nikkei 225
10,610.72 -25.99
(-0.24%)
Forex
USD-INR
95.97 0.01
(0.01%)
EUR-INR
108.89 -0.26
(-0.24%)
GBP-INR
126.98 -0.19
(-0.15%)
JPY-INR
0.61 0.00
(0.01%)

EQUITY - MARKET SCREENER

Gland Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
543245
INE068V01023
655.111941
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAND
33.93
47919.15
EPS(TTM)
Face Value()
Div & Yield %
85.6
1
0.69
 

South Indian Bank updates on appointment of Mahesh Muralidhar Pai as MD and CEO
Sep 16,2026
South Indian Bank announced that Mahesh Muralidhar Pai (DIN: 09164982) will be taking charge as MD & CEO of the Bank with effect from 01 October 2026.

Further, to facilitate an orderly transition and enable him to familiarise with the affairs, business operations, policies, systems, governance framework and key functions of the Bank before assuming charge as MD & CEO, the Board has approved that Mahesh Muralidhar Pai be appointed as “Officer on Special Duty (OSD)” for the interim period, from 16 September 2026 to 30 September 2026.